GSK unveils Target the Future, a global, multi-year program to help address key challenges affecting the multiple myeloma community

GSK unveils Target the Future, a global, multi-year program to help address key challenges affecting the multiple myeloma community

Source: 
Indiana Gazette
snippet: 

GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community.